Gilead Sciences, Inc. (GILD)
You are trying to access content that is part of a premium service.
If you are a premium service subscriber, log in here.
If you are not a premium service subscriber, click here to subscribe.
Article Excerpt
Today’s new recommendation comes from Stephen Leeb’s The Complete Investor.
“For more than a decade, drug company Gilead Sciences, Inc. (GILD) has been the leading provider of medicines to combat the HIV virus. While growth in sales of its HIV drugs has slowed, it remains in double digits. Moreover, the company…
Comments